Differential expression of the splicing regulatory factor genes during two-step chemical transformation in a

T Maeda1, H Hiranuma, A Jikko

  • 1Department of Radiology and Radiation Oncology, Osaka University School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan. tmaeda@radiol.dent.osaka-u.ac.jp

Carcinogenesis
|December 11, 1999
PubMed

Insights

Changes in splicing factor gene expression, including alternative splicing factor/splicing factor 2 (ASF/SF2) and U2 small nuclear ribonucleoprotein particles auxiliary factor 65 (U2AF(65)), occur during cellular transformation, potentially explaining aberrant alternative splicing in tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Alternative splicing is frequently altered in human tumors.
  • The underlying mechanisms driving these splicing changes during cancer development are not well understood.
  • Splicing regulatory factors play a crucial role in controlling alternative splicing patterns.

Purpose of the Study:

  • To investigate alterations in the expression of key splicing regulatory factors during in vitro cellular transformation.
  • To determine if changes in splicing factor gene expression correlate with the progression of cancer development.
  • To explore the potential link between altered splicing factor expression and aberrant alternative splicing observed in tumor cells.

Main Methods:

  • Utilized a two-step chemical transformation model using BALB/3T3 cells and derived cell lines (MT-5).
  • Examined mRNA expression levels of splicing regulatory factors, including alternative splicing factor/splicing factor 2 (ASF/SF2), heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2), and U2 small nuclear ribonucleoprotein particles auxiliary factor 65 (U2AF(65)), via Northern blotting.
  • Analyzed distinct mRNA isoforms using Reverse Transcription Polymerase Chain Reaction (RT-PCR).

Main Results:

  • ASF/SF2 mRNA levels decreased significantly (2-fold) in both initiated and transformed cells compared to parental cells.
  • hnRNP A2 mRNA expression showed no significant changes across the cell types.
  • U2AF(65) mRNA levels increased substantially (approximately 4.7-fold) with the progression of cellular transformation.
  • Distinct ASF/SF2 mRNA variants were detected in initiated and transformed cells, but not in parental cells.

Conclusions:

  • Gene expression of ASF/SF2 and U2AF(65) is demonstrably altered during in vitro chemical-induced cellular transformation.
  • Differential expression of splicing regulatory factors like ASF/SF2 and U2AF(65) is implicated as a causative factor for aberrant alternative splicing in tumor cells.
  • These findings provide mechanistic insights into how altered splicing contributes to cancer development.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then processed and...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...